Skip to main content
. 2021 Jun 10;58(9):4575–4587. doi: 10.1007/s12035-021-02412-y

Fig. 1.

Fig. 1

Schematic of the incidence of neurological symptoms and simplified coronavirus replication cycle showing the possible therapeutic targets with potential repurposed drugs. ACE2, angiotensin-converting enzyme carboxypeptidase 2